4-(4-Piperazin-2-yl-phenyl)morpholine,
864685-27-8,
4-[4-(Piperazin-2-yl)phenyl]morpholine,
4-(4-(piperazin-2-yl)phenyl)morpholine,
4-[4-(2-piperazinyl)phenyl]Morpholine,
4-(4-Piperazin-2-yl-phenyl)-morpholine,
AK-16326,
Morpholine,4-[4-(2-piperazinyl)phenyl]-,
SCHEMBL1639097,
CTK5F6739,
DTXSID40590137,
RTAZSKWNEMNKGR-UHFFFAOYSA-N,
KS-000025AB,
ANW-51339,
MFCD05864687,
SBB100293,
4-(4-piperazin-2-ylphenyl)morpholine,
AKOS015854473,
FS-2839,
4-(4-Piperazin-2-yl-phenyl);morpholine,
BR-16326,
FS011435,
AX8090815,
DB-076649,
morpholine, 4-[4-(2-piperazinyl)phenyl]-,
ST2417984,
TR-026921,
4CH-015679,
FT-0718867,
W8877,
S-4638,
4-(4-piperazin-2-yl-phenyl)morpholine, 95+%,
4-(4-piperazin-2-yl-phenyl)morpholine, AldrichCPR,
4 - (4 - Piperazin - 2 - yl - phenyl) - morpholine,
4- morpholine,
C14H21N3O,